[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SV1998000010A - Combinaciones para diabetes de sulfonilurea-glitazona. - Google Patents

Combinaciones para diabetes de sulfonilurea-glitazona.

Info

Publication number
SV1998000010A
SV1998000010A SV1998000010A SV1998000010A SV1998000010A SV 1998000010 A SV1998000010 A SV 1998000010A SV 1998000010 A SV1998000010 A SV 1998000010A SV 1998000010 A SV1998000010 A SV 1998000010A SV 1998000010 A SV1998000010 A SV 1998000010A
Authority
SV
El Salvador
Prior art keywords
combinations
glitazone
sulfonylurea
diabetes
antidiabetic agent
Prior art date
Application number
SV1998000010A
Other languages
English (en)
Inventor
Randall W Whitcomb
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV1998000010A publication Critical patent/SV1998000010A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LAS COMBINACIONES DE UN AGENTE ANTIDIABETICO DE SULFONILUREA Y UN AGENTE AINTIDIABETICO DE GLITAZONA SON DE UTILIDAD PARA TRATAR LA DIABETES MELLITUS Y PARA MEJORAR EL CONTROL GLUCEMICO
SV1998000010A 1997-02-19 1998-01-22 Combinaciones para diabetes de sulfonilurea-glitazona. SV1998000010A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3822497P 1997-02-19 1997-02-19

Publications (1)

Publication Number Publication Date
SV1998000010A true SV1998000010A (es) 1999-02-02

Family

ID=21898725

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1998000010A SV1998000010A (es) 1997-02-19 1998-01-22 Combinaciones para diabetes de sulfonilurea-glitazona.

Country Status (29)

Country Link
US (2) US5859037A (es)
EP (1) EP0957923A1 (es)
JP (1) JP2001512478A (es)
KR (1) KR20000071179A (es)
CN (1) CN1244801A (es)
AR (1) AR011829A1 (es)
AU (1) AU741215B2 (es)
BG (1) BG103671A (es)
BR (1) BR9714505A (es)
CA (1) CA2272478A1 (es)
CZ (1) CZ289299A3 (es)
EA (1) EA199900725A1 (es)
EE (1) EE9900345A (es)
GT (1) GT199800037A (es)
HN (1) HN1997000167A (es)
HU (1) HUP0001528A3 (es)
IL (1) IL130027A (es)
IS (1) IS5058A (es)
NO (1) NO993982L (es)
NZ (1) NZ336002A (es)
PA (1) PA8447401A1 (es)
PE (1) PE74399A1 (es)
PL (1) PL335166A1 (es)
SK (1) SK111899A3 (es)
SV (1) SV1998000010A (es)
TR (1) TR199902033T2 (es)
UY (1) UY24893A1 (es)
WO (1) WO1998036755A1 (es)
ZA (1) ZA981343B (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
NZ501260A (en) * 1997-06-18 2002-09-27 Smithkline Beecham P Treatment of diabetes with thiazolidinedione and metformin
KR20070011651A (ko) * 1997-06-18 2007-01-24 스미스클라인비이참피이엘시이 티아졸리딘디온 및 술포닐우레아를 사용한 당뇨병의 치료
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US7105552B2 (en) 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
WO1999065897A1 (en) 1998-06-19 1999-12-23 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
CN100352505C (zh) * 1998-12-24 2007-12-05 症变治疗公司 治疗糖尿病的fbp酶抑制剂与胰岛素致敏剂的组合
US7001746B1 (en) * 1999-01-29 2006-02-21 Artecel Sciences, Inc. Methods and compositions for the differentiation of human preadipocytes into adipocytes
CA2367955C (en) * 1999-03-15 2009-05-19 University Of British Columbia Abc1 polypeptide and methods and reagents for modulating cholesterol levels
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US7563775B2 (en) * 2000-11-01 2009-07-21 Betty C. Villafuerte Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes
US20060154864A1 (en) * 1999-11-01 2006-07-13 Emory University Transcript factor and an Akt substrate related to transcriptional action of insulin and applications of same
FR2802814B1 (fr) * 1999-12-23 2002-02-22 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des sulfonylurees
DE60103203T2 (de) * 2000-04-13 2005-05-04 Pfizer Products Inc., Groton Synergistische Wirkung von Glyburide und Milrinone
GB0014969D0 (en) * 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
KR200249057Y1 (ko) * 2001-03-22 2001-10-19 김진환 뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
US6492339B1 (en) 2001-05-23 2002-12-10 Insmed, Incorporated Compositions comprising D-chiro inositol and sulfonylureas and methods of treatment thereof
SE0101982D0 (sv) * 2001-06-01 2001-06-01 Astrazeneca Ab Pharmaceutical combination
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
EP2604266A1 (en) 2002-09-20 2013-06-19 Andrx Labs Llc Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040147564A1 (en) * 2003-01-29 2004-07-29 Rao Vinay U. Combinations of glimepiride and the thiazolidinedione for treatment of diabetes
GEP20084570B (en) 2003-10-31 2008-12-25 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
MXPA04009236A (es) * 2004-09-23 2006-03-27 Jorge Luis Rosado Loria Composicion sinergistica para el tratamiento de diabetes y sus comorbilidades.
US20060188590A1 (en) * 2005-01-05 2006-08-24 Mitsunori Ono Compositions for treating diabetes or obesity
TW200722088A (en) * 2005-05-27 2007-06-16 Sankyo Co Diabetes remedy
AU2006289259A1 (en) * 2005-09-08 2007-03-15 Uutech Limited Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function
US20090170762A1 (en) * 2005-09-08 2009-07-02 Uutech Limited Treatment of Diabetes Related Obesity
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
MXPA05013220A (es) * 2005-12-06 2007-06-05 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2.
ZA200805147B (en) 2005-12-22 2010-05-26 Takeda Pharmaceutical Solid preparation
WO2008026668A1 (fr) * 2006-08-31 2008-03-06 Daiichi Sankyo Company, Limited Composition médicale contenant un agent d'amélioration de la résistance à l'insuline
KR20140012199A (ko) 2007-03-30 2014-01-29 암브룩스, 인코포레이티드 변형된 ｆｇｆ-21 폴리펩티드 및 그 용도
WO2009073711A1 (en) 2007-12-04 2009-06-11 Remedy Pharmaceuticals, Inc. Improved formulations and methods for lyophilization and lyophilates provided thereby
FR2928836B1 (fr) * 2008-03-21 2011-08-26 Servier Lab Forme galenique secable permettant une liberation modifiee du principe actif
US11541029B2 (en) 2008-12-04 2023-01-03 Techfields Pharma Co., Ltd. High penetration compositions and their applications
US20110065756A1 (en) * 2009-09-17 2011-03-17 De Taeye Bart M Methods and compositions for treatment of obesity-related diseases
CA2780683A1 (en) * 2009-11-13 2011-05-19 Toray Industries, Inc. Therapeutic or prophylactic combination of a prostaglandin i2 and a thiazolidine for diabetes
US9241952B2 (en) 2010-05-24 2016-01-26 Ozstar Therapeutics Pty Ltd Method of treating type II diabetes, hyperglycemia or hypoglycemia by administering a synergistic combination of a sulphonylurea and inulin
CN103582463B (zh) 2011-01-19 2018-02-13 弗拉克泰尔实验室公司 用于组织处理的装置与方法
KR102104384B1 (ko) 2011-11-23 2020-04-27 오즈스타 테라피우틱스 피티와이 엘티디 개선된 상승작용성 항-당뇨병성 조성물
CN103159651B (zh) * 2011-12-14 2015-06-17 安徽贝克联合制药有限公司 磺酰脲胍及其制备方法和用途
JP6167115B2 (ja) 2012-02-27 2017-07-19 フラクティル ラボラトリーズ インコーポレイテッド 組織の治療のための熱切除システム、デバイスおよび方法
EP2838598B1 (en) 2012-04-19 2020-01-15 Fractyl Laboratories, Inc. Tissue expansion devices
WO2014022436A1 (en) 2012-07-30 2014-02-06 Fractyl Laboratories Inc. Electrical energy ablation systems, devices and methods for the treatment of tissue
WO2014026055A1 (en) 2012-08-09 2014-02-13 Fractyl Laboratories Inc. Ablation systems, devices and methods for the treatment of tissue
WO2014055997A1 (en) 2012-10-05 2014-04-10 Fractyl Laboratories Inc. Methods, systems and devices for performing multiple treatments on a patient
EP3003461B1 (en) 2013-06-04 2019-05-01 Fractyl Laboratories, Inc. Systems and devices for reducing the luminal surface area of the gastrointestinal tract
EP3043732B1 (en) 2013-09-12 2021-04-07 Fractyl Laboratories, Inc. Systems and devices for treatment of target tissue
JP6603660B2 (ja) 2013-11-22 2019-11-06 フラクティル ラボラトリーズ インコーポレイテッド 消化管における治療制約の生成のためのシステム、デバイスおよび方法
US10959774B2 (en) 2014-03-24 2021-03-30 Fractyl Laboratories, Inc. Injectate delivery devices, systems and methods
WO2016011269A1 (en) * 2014-07-16 2016-01-21 Fractyl Laboratories, Inc. Methods and systems for treating diabetes and related diseases and disorders
US9757535B2 (en) 2014-07-16 2017-09-12 Fractyl Laboratories, Inc. Systems, devices and methods for performing medical procedures in the intestine
US11185367B2 (en) 2014-07-16 2021-11-30 Fractyl Health, Inc. Methods and systems for treating diabetes and related diseases and disorders
KR102637699B1 (ko) 2014-10-24 2024-02-19 브리스톨-마이어스 스큅 컴퍼니 변형된 fgf-21 폴리펩티드 및 그의 용도
US12274703B2 (en) 2017-12-21 2025-04-15 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising a dementia
US12310967B2 (en) 2017-12-21 2025-05-27 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
CN108079000A (zh) * 2018-02-01 2018-05-29 湖南博隽生物医药有限公司 一种治疗糖尿病的药物组合物及其制备方法
US20230139684A1 (en) * 2019-11-22 2023-05-04 Brown University Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
AU706628B2 (en) * 1995-07-03 1999-06-17 Sankyo Company Limited Treatment of arteriosclerosis and xanthoma
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
BR9714505A (pt) 2000-03-21
PA8447401A1 (es) 2001-12-14
TR199902033T2 (xx) 2000-02-21
NO993982D0 (no) 1999-08-18
AU5590898A (en) 1998-09-09
EP0957923A1 (en) 1999-11-24
ZA981343B (en) 1998-11-16
PL335166A1 (en) 2000-04-10
PE74399A1 (es) 1999-08-20
JP2001512478A (ja) 2001-08-21
CA2272478A1 (en) 1998-08-27
AR011829A1 (es) 2000-09-13
CZ289299A3 (cs) 1999-11-17
WO1998036755A1 (en) 1998-08-27
KR20000071179A (ko) 2000-11-25
HN1997000167A (es) 1999-02-09
IL130027A (en) 2005-09-25
BG103671A (en) 2000-04-28
NZ336002A (en) 2002-03-28
NO993982L (no) 1999-08-18
EA199900725A1 (ru) 2000-04-24
IS5058A (is) 1999-05-27
CN1244801A (zh) 2000-02-16
GT199800037A (es) 1999-08-12
HUP0001528A2 (hu) 2000-11-28
UY24893A1 (es) 1998-07-10
AU741215B2 (en) 2001-11-29
IL130027A0 (en) 2000-02-29
US5859037A (en) 1999-01-12
US5972973A (en) 1999-10-26
HUP0001528A3 (en) 2000-12-28
SK111899A3 (en) 2000-09-12
EE9900345A (et) 2000-02-15

Similar Documents

Publication Publication Date Title
SV1998000010A (es) Combinaciones para diabetes de sulfonilurea-glitazona.
PA8484901A1 (es) Combinaciones para la diabetes
BR9913833A (pt) Método para tratar diabetes, empregando em inibidor de ap2 e combinação
DE69625157D1 (de) Behandlung des typ ii-deabetes mellitus mit amylinagonisten
DE59811840D1 (de) Zusammensetzung zur therapie von diabetes mellitus und fettsucht
GR980100463A (el) Χρηση μακρολιδιων στον ελεγχο ζιζανιων
PA8464901A1 (es) Procesos para la sintesis de 1,3-dioles
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
ATE433324T1 (de) Verwendung von glp-1 oder analoge zur behandlung von schlaganfall
WO2000021549A8 (en) A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
BR9204191A (pt) Composicao de isca e processo para controlar populacoes de besouro diabroticine,e isca
DE69015024D1 (de) Unter Feldeffekt-Emission arbeitende Schaltanordnung und deren Herstellungsverfahren.
ATE253299T1 (de) Darmfüllvorrichtung sowie maschine zum füllen von wurst-därmen
ES2110661T3 (es) Polipropilenos elastomeros modificados.
ES2136724T3 (es) Emulsion liofilizada, que contiene una sustancia activa.
EA200000140A1 (ru) Способ лечения диабета тиазолидиндионом, средством, усиливающим секрецию инсулина, и ингибитором альфа-глюкозидазы
EA200000040A1 (ru) Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы
ES2152315T3 (es) Xamoneline tartrato.
ECSP982417A (es) Combinaciones para diabetes de sulfonilurea glitazona
ECSP993207A (es) Combinaciones para la diabetes
UA41246C2 (uk) Похідні мільбеміцину, що мають пестицидну активність, спосіб лікування ендо- та ектопаразитних інфекцій, спосіб боротьби з комахами та кліщами
BR0013437A (pt) Método para tratamento de infestação do corpo por insetos
AR240480A1 (es) Composicion para el curtido de pieles de animales.
AR240479A1 (es) Un agente de curtido de cueros y el procedimiento para curtir.
ES2025117B3 (es) Un derivado de propanona opticamente activo y proceso para producir el mismo y su aplicacion.

Legal Events

Date Code Title Description
FG Grant